Novonix Ltd Adr Stock Performance
| NVX Stock | USD 1.49 0.03 1.97% |
On a scale of 0 to 100, Novonix holds a performance score of 6. The company secures a Beta (Market Risk) of -1.09, which conveys a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Novonix are expected to decrease slowly. On the other hand, during market turmoil, Novonix is expected to outperform it slightly. Please check Novonix's kurtosis, market facilitation index, and the relationship between the semi variance and rate of daily change , to make a quick decision on whether Novonix's current price movements will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Novonix Ltd ADR are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Novonix showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 78.7 M | |
| Total Cashflows From Investing Activities | -18.2 M |
Novonix Relative Risk vs. Return Landscape
If you would invest 120.00 in Novonix Ltd ADR on April 27, 2025 and sell it today you would earn a total of 29.00 from holding Novonix Ltd ADR or generate 24.17% return on investment over 90 days. Novonix Ltd ADR is generating 0.4981% of daily returns assuming volatility of 5.6452% on return distribution over 90 days investment horizon. In other words, 50% of stocks are less volatile than Novonix, and above 90% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Novonix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novonix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Novonix Ltd ADR, and traders can use it to determine the average amount a Novonix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0882
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NVX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.65 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.5 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Novonix is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novonix by adding it to a well-diversified portfolio.
Novonix Fundamentals Growth
Novonix Stock prices reflect investors' perceptions of the future prospects and financial health of Novonix, and Novonix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Novonix Stock performance.
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.14 | ||||
| Operating Margin | (7.86) % | ||||
| Current Valuation | 262.03 M | ||||
| Shares Outstanding | 159.11 M | ||||
| Price To Earning | 5.23 X | ||||
| Price To Book | 1.76 X | ||||
| Price To Sales | 41.31 X | ||||
| Revenue | 5.85 M | ||||
| EBITDA | (66.61 M) | ||||
| Cash And Equivalents | 207.08 M | ||||
| Cash Per Share | 1.71 X | ||||
| Total Debt | 70.42 M | ||||
| Debt To Equity | 0.17 % | ||||
| Book Value Per Share | 0.24 X | ||||
| Cash Flow From Operations | (40.42 M) | ||||
| Earnings Per Share | (0.81) X | ||||
| Total Asset | 226.1 M | ||||
| Retained Earnings | (259.67 M) | ||||
About Novonix Performance
Evaluating Novonix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Novonix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Novonix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Novonix Limited develops and supplies battery materials, equipment, and services to the lithium-ion battery market in North America. Novonix Limited was incorporated in 2012 and is based in Brisbane, Australia. Novonix is traded on NASDAQ Exchange in the United States.Things to note about Novonix Ltd ADR performance evaluation
Checking the ongoing alerts about Novonix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Novonix Ltd ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Novonix Ltd ADR had very high historical volatility over the last 90 days | |
| Novonix Ltd ADR may become a speculative penny stock | |
| Novonix Ltd ADR has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 5.85 M. Reported Net Loss for the year was (74.82 M) with profit before taxes, overhead, and interest of 4.08 M. | |
| Novonix Ltd ADR has about 207.08 M in cash with (40.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Novonix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Novonix's stock is overvalued or undervalued compared to its peers.
- Examining Novonix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Novonix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Novonix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Novonix's stock. These opinions can provide insight into Novonix's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Novonix Stock Analysis
When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.